1. Home
  2. PFX vs TLSA Comparison

PFX vs TLSA Comparison

Compare PFX & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFX
  • TLSA
  • Stock Information
  • Founded
  • PFX 2010
  • TLSA 2013
  • Country
  • PFX United States
  • TLSA United Kingdom
  • Employees
  • PFX N/A
  • TLSA N/A
  • Industry
  • PFX Finance: Consumer Services
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFX Finance
  • TLSA Health Care
  • Exchange
  • PFX Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • PFX 99.3M
  • TLSA 87.8M
  • IPO Year
  • PFX N/A
  • TLSA 2000
  • Fundamental
  • Price
  • PFX $49.87
  • TLSA $0.74
  • Analyst Decision
  • PFX
  • TLSA
  • Analyst Count
  • PFX 0
  • TLSA 0
  • Target Price
  • PFX N/A
  • TLSA N/A
  • AVG Volume (30 Days)
  • PFX 2.3K
  • TLSA 442.0K
  • Earning Date
  • PFX 02-06-2025
  • TLSA 01-28-2025
  • Dividend Yield
  • PFX N/A
  • TLSA N/A
  • EPS Growth
  • PFX N/A
  • TLSA N/A
  • EPS
  • PFX 9.13
  • TLSA N/A
  • Revenue
  • PFX $22,181,598.00
  • TLSA N/A
  • Revenue This Year
  • PFX $4.64
  • TLSA N/A
  • Revenue Next Year
  • PFX N/A
  • TLSA N/A
  • P/E Ratio
  • PFX $5.46
  • TLSA N/A
  • Revenue Growth
  • PFX 10.18
  • TLSA N/A
  • 52 Week Low
  • PFX $42.50
  • TLSA $0.41
  • 52 Week High
  • PFX $51.50
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • PFX 56.22
  • TLSA 44.91
  • Support Level
  • PFX $48.49
  • TLSA $0.68
  • Resistance Level
  • PFX $49.50
  • TLSA $0.80
  • Average True Range (ATR)
  • PFX 0.50
  • TLSA 0.08
  • MACD
  • PFX -0.13
  • TLSA 0.01
  • Stochastic Oscillator
  • PFX 59.82
  • TLSA 34.34

About PFX PhenixFIN Corporation

PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: